title: More research is needed to establish the benefit-risk profile of curcumin.
authors.forename: Estefanía
authors.initials: E
authors.lastname: Burgos-Morón
authors.forename: José Manuel
authors.initials: JM
authors.lastname: Calderón-Montaño
authors.forename: Concepción
authors.initials: C
authors.lastname: Pérez-Guerrero
authors.forename: Miguel
authors.initials: M
authors.lastname: López-Lázaro
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects; D003474:Curcumin / Q000009:adverse effects / Q000378:metabolism* / Q000627:therapeutic use; D004247:DNA / Q000378:metabolism*; D004587:Electrophoresis, Agar Gel; D006801:Humans; D007364:Intercalating Agents / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D007364:Intercalating Agents; D004247:DNA; D003474:Curcumin